We highly recommend enabling Javascript while using the BlackBoxRX site.

Amikacin Liposome

Risk of Increased Respiratory Adverse Reactions

  • ARIKAYCE has been associated with a risk of increased respiratory adverse reactions, including, hypersensitivity pneumonitis, hemoptysis, bronchospasm, and exacerbation of underlying pulmonary disease that have led to hospitalizations in some cases.

Patient Counseling Information

Medication Guides

Patient Medication Guide - Arikayce

Package Inserts

Amikacin Liposome

Additional Information

Updated October 2018